Microsurgical treatment of intracanalicular vestibular schwannomas.

Prog Neurol Surg

Department of Neurosurgery, Maison Blanche Hospital, University of Reims, Reims, France.

Published: January 2009

Early treatment of intracanalicular vestibular schwannomas (IVSs) may be advisable because their spontaneous course will show hearing loss in most cases. Advanced microsurgical techniques and continuous intraoperative monitoring of cranial nerves may allow hearing preservation (HP) without facial nerve damage. However, there are still controversies about the definition of HP and the best surgical approach that should be used. In this study, we reviewed the main data from the recent literature on IVS surgery and compared hearing, facial function and complication rates after the retrosigmoid and middle fossa approaches, respectively. The results showed that the average HP rate is approximately 45% after IVS surgery whatever the surgical route. HP varied widely depending on the audiometric criteria that were used for definition of serviceable hearing. There was a trend to show that middle fossa approach offered a better quality of postoperative hearing (not statistically significant), whereas the retrosigmoid approach offered a better facial nerve preservation and fewer complications (not statistically significant). We believe that the timing of treatment in the course of the disease and selection between radiosurgical versus microsurgical procedure are key issues in the management of IVS. Once open surgery has been decided, selection of the approach mainly depends on individual anatomical considerations and experience of the surgeon.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000156916DOI Listing

Publication Analysis

Top Keywords

treatment intracanalicular
8
intracanalicular vestibular
8
vestibular schwannomas
8
facial nerve
8
ivs surgery
8
middle fossa
8
approach offered
8
offered better
8
hearing
5
microsurgical treatment
4

Similar Publications

Canaliculops is a rare case of a medial canthal mass due to a non-infectious dilation of the canaliculus and easily mimics canaliculitis with canalicular dilation. We report a case of a 68-year-old woman with a five-year history of progressive swelling of the right upper eyelid. The patient was previously diagnosed with canaliculitis at other clinics and had a history of diabetes mellitus.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the effectiveness and safety of a dexamethasone intracanalicular insert (DEX) for treating allergic conjunctivitis (AC) in adults, comparing it to a placebo.
  • 96 participants were randomized into two groups (DEX and placebo) and underwent allergen challenges to assess symptoms like ocular itching and redness over 30 days.
  • Results showed that the DEX insert significantly reduced eye itching and redness compared to placebo without serious side effects, indicating it might be a safe and effective treatment option for AC.
View Article and Find Full Text PDF
Article Synopsis
  • A meta-analysis was conducted to assess the effectiveness and safety of DEXTENZA, a dexamethasone insert, for treating allergic conjunctivitis.
  • The study analyzed data from four randomized controlled trials with 323 participants, finding significant reductions in conjunctival itching and redness when using DEXTENZA compared to a placebo.
  • Overall, DEXTENZA showed promise as a reliable treatment option with no significant differences in adverse effects compared to placebo.
View Article and Find Full Text PDF

Dexamethasone Intracanalicular Insert versus Standard Topical Steroids for the Prophylaxis of Inflammation after Cataract Surgery.

Am J Ophthalmol

December 2024

Kellogg Eye Center and Department of Ophthalmology and Visual Sciences (J.N.S., H.L., C.T.H., S.I.M.), University of Michigan, Ann Arbor, Michigan, USA. Electronic address:

Purpose: To compare the efficacy of an intracanalicular dexamethasone intracanalicular insert (DII) to a topical prednisolone acetate 1% taper for preventing breakthrough inflammation (iritis or cystoid macular edema [CME]) during the first postoperative month (POM1) after cataract surgery.

Design: Retrospective, nonrandomized comparative interventional study.

Methods: Patients received either DII or topical prednisolone acetate 1% eyedrops (control) during POM1.

View Article and Find Full Text PDF

Purpose: To assess the efficiency and safety of an intracanalicular dexamethasone insert (Dextenza, Ocular Therapeutix, Inc) supplemented with a reduced-frequency topical drop regimen in mitigating pain and inflammation post-penetrating keratoplasty (PKP), Descemet stripping endothelial keratoplasty (DSEK), and Descemet membrane endothelial keratoplasty (DMEK), compared to standard topical corticosteroid therapy.

Patients And Methods: Eyes were categorized within the DSEK, DMEK, or PKP groups based on ocular characteristics and surgical indications. Randomized in a 1:1 ratio, the intervention group received Dextenza alongside a lowered drop frequency, while the control group followed a conventional drop protocol with no Dextenza.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!